Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia

被引：8

作者：

Gollamudi, Jahnavi ^{[1
]}

Sarvepalli, Shashank ^{[2
]}

Vadaparti Binf, Animesh ^{[3
]}

Alin, Tara ^{[4
,5
]}

Little, Jane A. ^{[4
,5
]}

Nayak, Lalitha ^{[6
]}

机构：

[1] Baylor Coll Med, Dept Internal Med, Div Hematol Oncol, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Internal Med, Div Gastroenterol, Houston, TX 77030 USA

[3] Guelph Univ, Dept Integrat Biol, Guelph, ON, Canada

[4] Univ N Carolina, Div Hematol, Chapel Hill, NC 27515 USA

[5] Univ N Carolina, UNC Blood Res Ctr, Dept Internal Med, Chapel Hill, NC 27515 USA

[6] Seidman Canc Ctr, Dept Internal Med, Div Hematol Oncol, Cleveland, OH USA

来源：

HEMOGLOBIN | 2021年 / 45卷 / 01期

关键词：

Leukocytosis; neutrophilia; predictors; sickle cell disease; venous thromboembolism (VTE);

D O I：

10.1080/03630269.2020.1869565

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Venous thromboembolism (VTE) in individuals with sickle cell disease is common and portends a poor prognosis. The role of leukocyte count and its subsets on risk of VTE in sickle cell disease are not known. We conducted a retrospective case-control study and analyzed for leukocyte count at the time of VTE and 3 months prior. Leukocyte and neutrophil counts were elevated at the time of VTE (p = 0.003 and p = 0.0006, respectively) and 3 months prior (p = 0.001 and p = 0.0096, respectively) when compared to controls. Baseline leukocytosis and neutrophilia may be associated with subsequent risk for thrombosis in sickle cell disease.

引用

页码：56 / 59

页数：4

共 50 条

[21] EXPLORING THE RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN CHILDREN WITH SICKLE CELL DISEASE
Agarwal, Shreya
Foster, Kayla
Johnson, Shaniqua
Shapiro, Mary
Han, HyoJyeong
Scheurer, Michael E.
Airewele, Gladstone
Sartain, Sarah E.
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E3 - E3
[22] Use of rivaroxaban in sickle cell disease and venous thromboembolism A case report
Rozi, Waail
Ali, Elrazi Awadelkarim Hamid
Al-Mashdali, Abdulrahman F.
Abdelrazek, Mohamed
Yassin, Mohamed A.
MEDICINE, 2021, 100 (51) : E27988
[23] Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study
Woods, Gary M.
Sharma, Ruchika
Creary, Susan
O'Brien, Sarah
Stanek, Joseph
Hor, Kan
Young, Jennifer
Dunn, Amy L.
Kumar, Riten
JOURNAL OF PEDIATRICS, 2018, 197 : 186 - +
[24] High incidence of venous thromboembolism recurrence in patients with sickle cell disease
Brunson, Ann
Keegan, Theresa
Mahajan, Anjlee
White, Richard
Wun, Ted
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) : 862 - 870
[25] How I diagnose and treat venous thromboembolism in sickle cell disease
Shet, Arun S.
Wun, Ted
BLOOD, 2018, 132 (17) : 1761 - 1769
[26] The possible role of reticulocytes in sickle cell disease associated thromboembolism
Thachil, Jecko
HEMATOLOGY, 2008, 13 (01) : 68 - 70
[27] The effect of anticoagulant choice on venous thromboembolism recurrence and bleeding in sickle cell disease
Gupta, Vishal K.
Strykowski, Rachel
Scarpato, Brittany
Lawrence, Romy
Khan, Sarah L.
Patel, Jay
Nouraie, S. Mehdi
Cohen, Robyn T.
Sloan, J. Mark
Klings, Elizabeth S.
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : E279 - E281
[28] Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery
Osei, Samuel K.
Long, Graham W.
Sharrak, Aryana
Derias, Nardin
Goodson III, Rocelious
Callahan, Rose E.
Studzinski, Diane M.
Brown, O. William
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2023, 11 (03) : 543 - 552
[29] Evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease
Kelley, Denise
Jones, Lauren Thornton
Wu, Jun
Bohm, Nicole
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (04) : 463 - 468
[30] Acute venous thromboembolism after initiation of voxelotor for treatment of sickle cell disease
Lemon, Natalie
Sterk, Ethan
Rech, Megan A.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 225.e1 - 225.e3

← 1 2 3 4 5 →